Trimetazidine protects cardiomyocytes against hypoxia-induced injury through ameliorates calcium homeostasis
Authors:
- 1 July 2015
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 236, 47-56
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31170893, 11372244)
This publication has 39 references indexed in Scilit:
- Trimetazidine Protects against Smoking-Induced Left Ventricular Remodeling via Attenuating Oxidative Stress, Apoptosis, and InflammationPLOS ONE, 2012
- Decreased cardiac L-type Ca2+ channel activity induces hypertrophy and heart failure in miceJournal of Clinical Investigation, 2012
- Diabetic CardiomyopathyJournal of Cardiac Failure, 2010
- Calcium Cycling and Signaling in Cardiac MyocytesAnnual Review of Physiology, 2008
- Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca2+ release channelJournal of Clinical Investigation, 2007
- The role of calcium in hypoxia-induced signal transduction and gene expressionCell Calcium, 2004
- Hypoxia sensing and pathways of cytosolic Ca2+ increasesCell Calcium, 2004
- Cardiac excitation–contraction couplingNature, 2002
- p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes.Journal of Clinical Investigation, 1997
- Limitation of Infarct Size by Trimetazidine in the RabbitThe American Journal of Cardiology, 1995